Literature DB >> 23765175

First study of the C2491t nonsense mutation frequency in moroccan healthy population.

K Hamzi1, B Diakité, W Hmimech, S Nadifi.   

Abstract

The mutation FV Leiden (G1691A) is the most common mutation worldwide with a variable allelic frequency between countries. More frequent in the European and Caucasian populations and rare or absent in African native population, the FVL was studied in the Moroccan population (They-They et al. Ann Hum Biol 37(6):767-777, 2010) and is totally absent as reported previously by (Mathonnet et al. Thromb Haemost 88(6):1073-1074, 2002). Here, another mutation in FV (Q773Term) was detected in a Moroccan patient, which took our interest for this study and establishes the first epidemiological database for future associated studies concerning neurovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23765175     DOI: 10.1007/s12031-013-0045-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  9 in total

1.  Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.

Authors:  R van Wijk; K Nieuwenhuis; M van den Berg; E G Huizinga; B B van der Meijden; R J Kraaijenhagen; W W van Solinge
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

2.  Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population.

Authors:  Florence Mathonnet; Sellama Nadifi; Valérie Serazin-Leroy; Mbarka Dakouane; Yves Giudicelli
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249

3.  Parahaemophilia; haemorrhagic diathesis due to absence of a previously unknown clotting factor.

Authors:  P A OWREN
Journal:  Lancet       Date:  1947-04-05       Impact factor: 79.321

4.  Thalamic stroke and congenital factor V deficiency.

Authors:  P Petiot; B Croisile; C Confavreux; G Aimard; M Trillet; P Ffrench; M Dechavanne
Journal:  Stroke       Date:  1991-12       Impact factor: 7.914

Review 5.  Coagulation factor V: an old star shines again.

Authors:  J Rosing; G Tans
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

6.  Prevalence of angiotensin-converting enzyme, methylenetetrahydrofolate reductase, Factor V Leiden, prothrombin and apolipoprotein E gene polymorphisms in Morocco.

Authors:  Thierry Paluku They-They; Khalil Hamzi; Mohamed Taha Moutawafik; Hanane Bellayou; Mariame El Messal; Sellama Nadifi
Journal:  Ann Hum Biol       Date:  2010-08-05       Impact factor: 1.533

7.  Recurrent thrombophlebitis and pulmonary emboli in congenital factor 5 deficiency.

Authors:  N E Reich; G C Hoffman; V G deWolfe; H S Van Ordstrand
Journal:  Chest       Date:  1976-01       Impact factor: 9.410

8.  Human factor Va1 and factor Va2: properties in the procoagulant and anticoagulant pathways.

Authors:  L Hoekema; G A Nicolaes; H C Hemker; G Tans; J Rosing
Journal:  Biochemistry       Date:  1997-03-18       Impact factor: 3.162

Review 9.  Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases.

Authors:  L T Goodnough; H Saito; O D Ratnoff
Journal:  Medicine (Baltimore)       Date:  1983-07       Impact factor: 1.889

  9 in total
  2 in total

1.  First study of C2491T FV mutation with ischaemic stroke risk in Morocco.

Authors:  Brehima Diakite; Khalil Hamzi; Wiam Hmimech; Sellama Nadifi
Journal:  J Genet       Date:  2015-06       Impact factor: 1.166

2.  G2691A and C2491T mutations of factor V gene and pre-disposition to myocardial infarction in Morocco.

Authors:  Wiam Hmimech; Brehima Diakite; Hind Hassani Idrissi; Khalil Hamzi; Farah Korchi; Dalila Baghdadi; Rachida Habbal; Sellama Nadifi
Journal:  Biomed Rep       Date:  2016-09-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.